The Significance of Hürthle Cells in Thyroid Disease
- 30 September 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 16 (10) , 1380-1387
- https://doi.org/10.1634/theoncologist.2010-0253
Abstract
Learning Objectives: After completing this course, the reader will be able to: Enumerate the variable thyroid pathological conditions in which Hürthle cells are seen and explain the significance of the findings within the appropriate clinical context.Describe the various means by which Hürthle cell neoplasms may be evaluated and their value in determining the likelihood of a benign or malignant lesion. CME This article is available for continuing medical education credit at CME.TheOncologist.com Hürthle cells (HCs) and HC change, along with the frequently employed synonyms “oncocytes/oncocytic change” or “oxyphils/oxyphilic change,” are not infrequently described on fine-needle aspiration biopsy (FNAB) reports of thyroid lesions. The description of HCs on FNAB reports may cause significant concern to the clinician; however, placing the finding in the appropriate clinical context may alleviate some anxiety. Not all oxyphilic cells are true HCs and not every aspirate containing HCs is or should be considered equivalent to an HC neoplasm (HCN). There are many benign thyroid lesions associated with HCs or HC change. For clinicians, it may be difficult to discern the significance of these findings and to determine an appropriate course of action. A skilled and experienced cytopathologist is invaluable in discriminating the subtle features that distinguish these lesions from those warranting a more aggressive approach. The diagnosis of HC carcinoma relies on histopathologic scrutiny and evidence of capsular and/or vascular invasion or metastasis to lymph nodes or distant organs. Many investigators have sought clinical, radiographic, cytological, genetic, and other factors to attempt to discriminate preoperatively between benign and malignant HCNs. To date, none have been definitively proven to be reliable. For now, because of the inability to determine the benign or malignant nature of such neoplasms based on cytology alone, a surgical approach is warranted.Keywords
This publication has 43 references indexed in Scilit:
- Expression Profiling of Difficult-to-diagnose Thyroid Histologic Subtypes Shows Distinct Expression Profiles and Identify Candidate Diagnostic microRNAsAnnals of Surgical Oncology, 2011
- Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposiumCytopathology, 2010
- Use of Ultrasound in the Management of Thyroid CancerThe Oncologist, 2010
- HURTHLE CELL NEOPLASM OF THE THYROID GLANDAnz Journal of Surgery, 2008
- HURTHLE CELL NEOPLASM OF THE THYROID GLANDAnz Journal of Surgery, 2008
- Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: A dilemma in the management of nodular thyroid diseaseSurgery, 2005
- The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular diseaseEuropean Journal of Surgical Oncology, 2004
- Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroidCancer, 2002
- Cytodiagnosis of benign and malignant hürthle cell lesions of the thyroid by fine‐needle aspiration biopsyDiagnostic Cytopathology, 1999
- Hürthle Cell Neoplasms of the ThyroidAnnals of Surgery, 1998